Literature DB >> 26895835

Loss of Fancc Impairs Antibody-Secreting Cell Differentiation in Mice through Deregulating the Wnt Signaling Pathway.

Mathieu Sertorio1, Surya Amarachintha1, Andrew Wilson1, Qishen Pang2.   

Abstract

Fanconi anemia (FA) is characterized by a progressive bone marrow failure and an increased incidence of cancer. FA patients have high susceptibility to immune-related complications such as infection and posttransplant graft-versus-host disease. In this study, we investigated the effect of FA deficiency in B cell function using the Fancc mouse model. Fancc(-/-) B cells show a specific defect in IgG2a switch and impaired Ab-secreting cell (ASC) differentiation. Global transcriptome analysis of naive B cells by mRNA sequencing demonstrates that FA deficiency deregulates a network of genes involved in immune function. Significantly, many genes implicated in Wnt signaling were aberrantly expressed in Fancc(-/-) B cells. Consistently, Fancc(-/-) B cells accumulate high levels of β-catenin under both resting and stimulated conditions, suggesting hyperactive Wnt signaling. Using an in vivo Wnt GFP reporter assay, we verified the upregulation of Wnt signaling as a potential mechanism responsible for the impaired Fancc(-/-) B cell differentiation. Furthermore, we showed that Wnt signaling inhibits ASC differentiation possibly through repression of Blimp1 and that Fancc(-/-) B cells are hypersensitive to Wnt activation during ASC differentiation. Our findings identify Wnt signaling as a physiological regulator of ASC differentiation and establish a role for the Wnt pathway in normal B cell function and FA immune deficiency.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26895835      PMCID: PMC4799755          DOI: 10.4049/jimmunol.1501056

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  Regulation of plasma-cell development.

Authors:  Miriam Shapiro-Shelef; Kathryn Calame
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

2.  Stat1-dependent synergistic activation of T-bet for IgG2a production during early stage of B cell activation.

Authors:  Weifeng Xu; J Jillian Zhang
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

Review 3.  From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias.

Authors:  Mihai G Netea; Jos W M Van der Meer; Roger P Sutmuller; Gosse J Adema; Bart-Jan Kullberg
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene.

Authors:  M A Whitney; G Royle; M J Low; M A Kelly; M K Axthelm; C Reifsteck; S Olson; R E Braun; M C Heinrich; R K Rathbun; G C Bagby; M Grompe
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

5.  Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype.

Authors:  T Usui; Y Wakatsuki; Y Matsunaga; S Kaneko; H Koseki; T Kita; H Kosek
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

6.  Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation.

Authors:  Y Lin; K Wong; K Calame
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

7.  Frizzled 9 knock-out mice have abnormal B-cell development.

Authors:  Erik A Ranheim; Helen C K Kwan; Tannishtha Reya; Yu-Ker Wang; Irving L Weissman; Uta Francke
Journal:  Blood       Date:  2004-11-30       Impact factor: 22.113

8.  The cell cycle of lymphocytes in Fanconi anemia.

Authors:  B Dutrillaux; A Aurias; A M Dutrillaux; D Buriot; M Prieur
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

9.  Prostaglandin E2-mediated enhancement of human plasma cell differentiation.

Authors:  P M Lydyard; J Brostoff; B N Hudspith; H Parry
Journal:  Immunol Lett       Date:  1982-03       Impact factor: 3.685

10.  Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow.

Authors:  Miriam Shapiro-Shelef; Kuo-I Lin; David Savitsky; Jerry Liao; Kathryn Calame
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

View more
  5 in total

1.  Common Variable Immunodeficiency Caused by FANC Mutations.

Authors:  Yujin Sekinaka; Noriko Mitsuiki; Kohsuke Imai; Miharu Yabe; Hiromasa Yabe; Kanako Mitsui-Sekinaka; Kenichi Honma; Masatoshi Takagi; Ayako Arai; Kenichi Yoshida; Yusuke Okuno; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Hideki Muramatsu; Seiji Kojima; Asuka Hira; Minoru Takata; Osamu Ohara; Seishi Ogawa; Tomohiro Morio; Shigeaki Nonoyama
Journal:  J Clin Immunol       Date:  2017-05-11       Impact factor: 8.317

2.  Identification of Three Novel Mutations in the FANCA, FANCC, and ITGA2B Genes by Whole Exome Sequencing.

Authors:  Samira Negahdari; Mina Zamani; Tahereh Seifi; Sahar Sedighzadeh; Neda Mazaheri; Jawaher Zeighami; Alireza Sedaghat; Alihossein Saberi; Mohammad Hamid; Bijan Keikhaei; Ramin Radpour; Gholamreza Shariati; Hamid Galehdari
Journal:  Int J Prev Med       Date:  2020-08-06

3.  BATF regulates the expression of Nfil3, Wnt10a and miR155hg for efficient induction of antibody class switch recombination in mice.

Authors:  Rosemary E Morman; Patrick G Schweickert; Stephen F Konieczny; Elizabeth J Taparowsky
Journal:  Eur J Immunol       Date:  2018-06-26       Impact factor: 5.532

4.  Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity.

Authors:  Limei Wu; Surya Amarachintha; Jian Xu; Frank Oley; Wei Du
Journal:  Br J Haematol       Date:  2018-08-14       Impact factor: 6.998

5.  Lymphopenia With Clinical and Laboratory Features of Combined Immune Deficiency in an 11-Year-Old Female With FANCD2 Variants and Fanconi Anemia.

Authors:  Roman Deniskin; Ghadir S Sasa; Sarada L Nandiwada; Nicholas L Rider
Journal:  Front Pediatr       Date:  2019-01-18       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.